Annual Current Assets
$14.06 M
-$2.51 M-15.13%
31 December 2023
Summary:
GT Biopharma annual total current assets is currently $14.06 million, with the most recent change of -$2.51 million (-15.13%) on 31 December 2023. During the last 3 years, it has risen by +$8.39 million (+148.30%). GTBP annual current assets is now -56.31% below its all-time high of $32.17 million, reached on 31 December 2021.GTBP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$6.76 M
-$2.51 M-27.06%
30 September 2024
Summary:
GT Biopharma quarterly total current assets is currently $6.76 million, with the most recent change of -$2.51 million (-27.06%) on 30 September 2024. Over the past year, it has dropped by -$9.29 million (-57.89%). GTBP quarterly current assets is now -82.92% below its all-time high of $39.57 million, reached on 30 June 2021.GTBP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.1% | -57.9% |
| 3 y3 years | +148.3% | -81.1% |
| 5 y5 years | +10000.0% | +1905.6% |
GTBP Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.3% | +148.3% | -81.1% | at low |
| 5 y | 5 years | -56.3% | >+9999.0% | -82.9% | +3495.2% |
| alltime | all time | -56.3% | >+9999.0% | -82.9% | >+9999.0% |
GT Biopharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.76 M(-27.1%) |
| June 2024 | - | $9.27 M(-6.3%) |
| Mar 2024 | - | $9.88 M(-29.7%) |
| Dec 2023 | $53.00 K(-69.5%) | $14.06 M(-12.4%) |
| Sept 2023 | - | $16.05 M(-10.9%) |
| June 2023 | - | $18.02 M(-9.6%) |
| Mar 2023 | - | $19.94 M(+20.4%) |
| Dec 2022 | $174.00 K(>+9900.0%) | $16.56 M(-20.6%) |
| Sept 2022 | - | $20.87 M(-12.8%) |
| June 2022 | - | $23.95 M(-11.9%) |
| Mar 2022 | - | $27.19 M(-15.5%) |
| Dec 2021 | $0.00(0.0%) | $32.17 M(-10.1%) |
| Sept 2021 | - | $35.80 M(-9.5%) |
| June 2021 | - | $39.57 M(+43.1%) |
| Mar 2021 | - | $27.64 M(+388.3%) |
| Dec 2020 | $0.00(-100.0%) | $5.66 M(+579.6%) |
| Sept 2020 | - | $833.00 K(-14.2%) |
| June 2020 | - | $971.00 K(+416.5%) |
| Mar 2020 | - | $188.00 K(-31.4%) |
| Dec 2019 | $122.00 K(-99.5%) | $274.00 K(-18.7%) |
| Sept 2019 | - | $337.00 K(+17.8%) |
| June 2019 | - | $286.00 K(+266.7%) |
| Mar 2019 | - | $78.00 K(-13.3%) |
| Dec 2018 | $25.31 M(-90.0%) | $90.00 K(-92.8%) |
| Sept 2018 | - | $1.25 M(+13.8%) |
| June 2018 | - | $1.10 M(-61.8%) |
| Mar 2018 | - | $2.87 M(+398.3%) |
| Dec 2017 | $253.79 M(>+9900.0%) | $576.00 K(-78.9%) |
| Sept 2017 | - | $2.73 M(+6905.1%) |
| June 2017 | - | $39.00 K(-83.4%) |
| Mar 2017 | - | $235.00 K(+1019.0%) |
| Dec 2016 | $4000.00(-20.0%) | $21.00 K(-86.5%) |
| Sept 2016 | - | $156.00 K(-56.3%) |
| June 2016 | - | $357.00 K(+1015.6%) |
| Mar 2016 | - | $32.00 K(-34.7%) |
| Dec 2015 | $5000.00(-16.7%) | $49.00 K(+11.4%) |
| Sept 2015 | - | $44.00 K(-65.4%) |
| June 2015 | - | $127.00 K(-91.1%) |
| Mar 2015 | - | $1.42 M(+61.0%) |
| Dec 2014 | $6000.00(-72.7%) | $882.00 K(+27.8%) |
| Sept 2014 | - | $690.00 K(+2056.3%) |
| June 2014 | - | $32.00 K(-58.4%) |
| Mar 2014 | - | $77.00 K(-38.4%) |
| Dec 2013 | $22.00 K(-8.3%) | $125.00 K(+212.5%) |
| Sept 2013 | - | $40.00 K(-69.5%) |
| June 2013 | - | $131.00 K(+39.4%) |
| Mar 2013 | - | $94.00 K(-53.5%) |
| Dec 2012 | $24.00 K(-4.0%) | $202.00 K(+176.7%) |
| Sept 2012 | - | $73.00 K(-33.0%) |
| June 2012 | - | $109.00 K(-24.3%) |
| Mar 2012 | - | $144.00 K(+38.5%) |
| Dec 2011 | $25.00 K(-47.9%) | $104.00 K(-69.7%) |
| Sept 2011 | - | $343.00 K(+76.8%) |
| June 2011 | - | $194.00 K(+102.1%) |
| Mar 2011 | - | $96.00 K(-29.9%) |
| Dec 2010 | $48.00 K(-47.3%) | $137.00 K(-47.1%) |
| Sept 2010 | - | $259.00 K(-57.5%) |
| June 2010 | - | $610.00 K(-27.4%) |
| Mar 2010 | - | $840.00 K(-35.0%) |
| Dec 2009 | $91.00 K(-71.1%) | $1.29 M(+310.5%) |
| Sept 2009 | - | $315.00 K(-11.3%) |
| June 2009 | - | $355.00 K(+38.1%) |
| Mar 2009 | - | $257.00 K(-6.5%) |
| Dec 2008 | $315.00 K(-85.9%) | $275.00 K(-17.9%) |
| Sept 2008 | - | $335.00 K(-59.1%) |
| June 2008 | - | $820.00 K(-68.1%) |
| Mar 2008 | - | $2.57 M(-2.2%) |
| Dec 2007 | $2.23 M(-2.9%) | $2.63 M(-17.3%) |
| Sept 2007 | - | $3.18 M(+7.5%) |
| June 2007 | - | $2.96 M(+12.2%) |
| Mar 2007 | - | $2.63 M(-53.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $2.30 M(-2.9%) | $5.70 M(+8.0%) |
| Sept 2006 | - | $5.28 M(+1.4%) |
| June 2006 | - | $5.21 M(-7.0%) |
| Mar 2006 | - | $5.60 M(+2.9%) |
| Dec 2005 | $2.37 M(+152.7%) | $5.44 M(+19.6%) |
| Sept 2005 | - | $4.55 M(-12.1%) |
| June 2005 | - | $5.18 M(-9.6%) |
| Mar 2005 | - | $5.72 M(-24.1%) |
| Dec 2004 | $936.00 K(+3.3%) | $7.54 M(+357.0%) |
| Sept 2004 | - | $1.65 M(-9.0%) |
| June 2004 | - | $1.81 M(+71.8%) |
| Mar 2004 | - | $1.06 M(-0.1%) |
| Dec 2003 | $906.00 K(-3.0%) | $1.06 M(+3.2%) |
| Sept 2003 | - | $1.02 M(+10.0%) |
| June 2003 | - | $931.00 K(-11.3%) |
| Mar 2003 | - | $1.05 M(-0.1%) |
| Dec 2002 | $934.00 K(-8.0%) | $1.05 M(-8.9%) |
| Sept 2002 | - | $1.15 M(-28.1%) |
| June 2002 | - | $1.60 M(-16.6%) |
| Mar 2002 | - | $1.92 M(+172.5%) |
| Dec 2001 | $1.01 M(-40.7%) | $706.00 K(-22.2%) |
| Sept 2001 | - | $908.00 K(-38.1%) |
| June 2001 | - | $1.47 M(-45.2%) |
| Mar 2001 | - | $2.68 M(-31.6%) |
| Dec 2000 | $1.71 M(-12.6%) | $3.91 M(-27.0%) |
| Sept 2000 | - | $5.36 M(-18.2%) |
| June 2000 | - | $6.55 M(+4.1%) |
| Mar 2000 | - | $6.29 M(+95.2%) |
| Dec 1999 | $1.96 M(-66.2%) | $3.23 M(+0.8%) |
| Sept 1999 | - | $3.20 M(-22.0%) |
| June 1999 | - | $4.10 M(-12.8%) |
| Mar 1999 | - | $4.70 M(-13.0%) |
| Dec 1998 | $5.80 M(-21.6%) | $5.40 M(-21.7%) |
| Sept 1998 | - | $6.90 M(+7.8%) |
| June 1998 | - | $6.40 M(+88.2%) |
| Mar 1998 | - | $3.40 M(-34.6%) |
| Dec 1997 | $7.40 M(+25.4%) | $5.20 M(+10.6%) |
| Sept 1997 | - | $4.70 M(-14.5%) |
| June 1997 | - | $5.50 M(+189.5%) |
| Mar 1997 | - | $1.90 M(-9.5%) |
| Dec 1996 | $5.90 M(-16.9%) | $2.10 M(+5.0%) |
| Sept 1996 | - | $2.00 M(-23.1%) |
| June 1996 | - | $2.60 M(-3.7%) |
| Mar 1996 | - | $2.70 M(-3.6%) |
| Dec 1995 | $7.10 M(-12.3%) | $2.80 M(-9.7%) |
| Sept 1995 | - | $3.10 M(0.0%) |
| June 1995 | - | $3.10 M(+6.9%) |
| Mar 1995 | - | $2.90 M(-6.5%) |
| Dec 1994 | $8.10 M(+3950.0%) | $3.10 M(-6.1%) |
| Sept 1994 | - | $3.30 M(+17.9%) |
| June 1994 | - | $2.80 M(-3.4%) |
| Mar 1994 | - | $2.90 M(0.0%) |
| Dec 1993 | $200.00 K(0.0%) | $2.90 M(-12.1%) |
| Sept 1993 | - | $3.30 M(0.0%) |
| June 1993 | - | $3.30 M(-29.8%) |
| Mar 1993 | - | $4.70 M(0.0%) |
| Dec 1992 | $200.00 K(0.0%) | $4.70 M(+4.4%) |
| Sept 1992 | - | $4.50 M(-2.2%) |
| June 1992 | - | $4.60 M(+7.0%) |
| Mar 1992 | - | $4.30 M(-6.5%) |
| Dec 1991 | $200.00 K(+100.0%) | $4.60 M(-11.5%) |
| Sept 1991 | - | $5.20 M(+6.1%) |
| Dec 1990 | $100.00 K(0.0%) | $4.90 M(+14.0%) |
| Dec 1989 | $100.00 K(-66.7%) | $4.30 M(+34.4%) |
| Dec 1988 | $300.00 K(-40.0%) | $3.20 M(+14.3%) |
| Dec 1987 | $500.00 K(+25.0%) | $2.80 M(-3.4%) |
| Dec 1986 | $400.00 K(0.0%) | $2.90 M(+3.6%) |
| Dec 1985 | $400.00 K(0.0%) | $2.80 M(-17.6%) |
| Dec 1984 | $400.00 K(0.0%) | - |
| Dec 1984 | - | $3.40 M |
| Feb 1984 | $400.00 K | - |
FAQ
- What is GT Biopharma annual total current assets?
- What is the all time high annual current assets for GT Biopharma?
- What is GT Biopharma annual current assets year-on-year change?
- What is GT Biopharma quarterly total current assets?
- What is the all time high quarterly current assets for GT Biopharma?
- What is GT Biopharma quarterly current assets year-on-year change?
What is GT Biopharma annual total current assets?
The current annual current assets of GTBP is $14.06 M
What is the all time high annual current assets for GT Biopharma?
GT Biopharma all-time high annual total current assets is $32.17 M
What is GT Biopharma annual current assets year-on-year change?
Over the past year, GTBP annual total current assets has changed by -$2.51 M (-15.13%)
What is GT Biopharma quarterly total current assets?
The current quarterly current assets of GTBP is $6.76 M
What is the all time high quarterly current assets for GT Biopharma?
GT Biopharma all-time high quarterly total current assets is $39.57 M
What is GT Biopharma quarterly current assets year-on-year change?
Over the past year, GTBP quarterly total current assets has changed by -$9.29 M (-57.89%)